§ BIOTECHNOLOGY
USD · Biotechnology

TNYA

TENAYA THERAPEUTICS INC
USDSector · Biotechnology
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
54 increased/new, 19 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
VANGUARD CAPITAL MANAGEMENT LLC8.5Mn/an/a
Millennium Management5.5M0.0%+18%
Empery Asset Management, LP4.3M3.6%−21%
Citadel Advisors4.2M0.0%±0%
Renaissance Technologies3.7M0.0%+101%
BlackRock, Inc.3.7M0.0%−6%
◇ AC INTELLIGENCE

Top institutional owners for TNYA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER69.8% · 0 holders
OTHER18.3% · 73 holders
TACTICAL / MACRO4.5% · 2 holders
SYSTEMATIC / QUANT3.3% · 5 holders
PASSIVE / INDEX2.5% · 5 holders
DEALER / BANK1.5% · 15 holders
QUALITY / COMPOUNDER0.0% · 3 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for TNYA in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention TNYA yet.